23 Results for "

MYC/MAX

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "MYC/MAX" in MCE Product Catalog:

  • Targets Recommended:
60
60 Publications Verification
Cat. No.: HY-12702
CAS No.: 403811-55-2
Purity:  99.49%
Target:  

c-Myc Autophagy

Research Areas:  

Cancer

10058-F4 is a c-Myc inhibitor that prevents c-Myc-Max dimerization and transactivation of c-Myc target gene expression.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100669
CAS No.: 944547-46-0
Purity:  98.11%
Target:  

c-Myc Autophagy

Research Areas:  

Cancer

Mycro 3 is an orally active, potent and selective inhibitor of Myc-associated factor X (MAX) dimerization. Mycro 3 also inhibit DNA binding of c-Myc . Mycro 3 could be used for the research of pancreatic cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100996
CAS No.: 413611-93-5
Purity:  99.63%
Target:  

c-Myc Autophagy

Research Areas:  

Cancer

10074-G5 is an inhibitor of c-Myc-Max dimerization with an IC50 of 146 μM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122683
CAS No.: 2089-82-9
Purity:  99.47%
Target:  

c-Myc

Research Areas:  

Cancer

sAJM589 is a Myc inhibitor which potently disrupts the Myc-Max heterodimer with an IC50 of 1.8 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12703
CAS No.: 1151813-61-4
Purity:  98.94%
Target:  

c-Myc Autophagy

Research Areas:  

Cancer

KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-144878
CAS No.: 2361742-30-3
Purity:  99.93%
Target:  

c-Myc

Research Areas:  

Cancer

VPC-70619 is a potent N-Myc inhibitor. VPC-70619 blocks the binding of the N-Myc-Max heterocomplex to the DNA E-box and exhibits potent inhibitory activity against N-Myc-dependent cell lines. VPC-70619 can partially reverse paclitaxel (HY-B0015) resistance in cells by reducing MYCN expression. VPC-70619 can be used for cancer research (e.g., neuroblastoma and thyroid cancer) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124675
CAS No.: 681282-09-7
Purity:  98.14%
Synonyms: NSC354961
Target:  

c-Myc Apoptosis

Research Areas:  

Cancer

MYCMI-6 (NSC354961) is a potent and selective endogenous MYC:MAX protein interactions inhibitor. MYCMI-6 blocks MYC-driven transcription and binds selectively to the MYC bHLHZip domain with a Kd of 1.6 μM. MYCMI-6 inhibits tumor cell growth in a MYC-dependent manner (IC50<0.5 μM). MYCMI-6 is not cytotoxic to normal human cells. MYCMI-6 induces apoptosis .
loading...
    loading...
Cat. No.: HY-147291
CAS No.: 13571-44-3
Purity:  99.92%
Target:  

c-Myc PARP Apoptosis

Research Areas:  

Cancer

VPC-70063 is a potent Myc-Max inhibitor with an IC50 value of 8.9 μM for Myc-Max transcriptional activity inhibition. VPC-70063 reduces UBE2C promotor activity and AR-V7 levels, and induces PARP cleavage. VPC-70063 induces apoptosis and blocks Myc-Max interactions with DNA. VPC-70063 can be used for researching anticancer .
loading...
    loading...
Cat. No.: HY-22445
CAS No.: 667909-97-9
Target:  

c-Myc

Research Areas:  

Cancer

MY05 selectively targets c-MYC in cells and disrupts MYC-MAX interaction. MY05 engages intracellular c-MYC, modulates c-MYC thermal stability, reduces c-MYC transcriptional targets, and possesses anticancer activity (TNBC, Triple-Negative Breast Cancer) .
loading...
    loading...
Cat. No.: HY-126979
CAS No.: 314049-21-3
Purity:  99.81%
Target:  

c-Myc

Research Areas:  

Cancer

Mycro2 is an inhibitor of c-Myc/Max dimer and DNA binding, with an IC50 value of 23 μM for the inhibition of Myc/Max DNA binding activity. Mycro2 can inhibit c-myc-dependent cell proliferation, gene transcription and oncogenic transformation .
loading...
    loading...
Cat. No.: HY-125978
CAS No.: 389076-27-1
Purity:  97.04%
Target:  

c-Myc

Research Areas:  

Cancer

JY-3-094 is a Myc inhibitor that inhibits Myc-Max heterodimer formation (IC50: 33 μM) .
loading...
    loading...
Cat. No.: HY-134975
CAS No.: 886053-73-2
Purity:  98.53%
Target:  

c-Myc

Research Areas:  

Cancer

NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM. NY2267 inhibits Myc- and Jun-induced transcriptional activation .
loading...
    loading...
Cat. No.: HY-125636
CAS No.: 313987-85-8
Target:  

c-Myc

Research Areas:  

Cancer

Mycro1 is an inhibitor of c-Myc/Max dimer and DNA binding, with an IC50 value of 30 μM for the inhibition of Myc/Max DNA binding activity. Mycro1 can inhibit c-myc-dependent cell proliferation, gene transcription and oncogenic transformation .
loading...
    loading...
Cat. No.: HY-159756B
Target:  

c-Myc

Research Areas:  

Cancer

KI-MS2-008 is a selective Max binder. KI-MS2-008 results in the stabilization of Max homodimers and the attenuation of Myc. KI-MS2-008 has anticancer activity against Myc-dependent cancer .
loading...
    loading...
Cat. No.: HY-178045
CAS No.: 3109265-41-7
Target:  

c-Myc

Research Areas:  

Cancer

MYC-IN-4 is a MYC inhibitor. MYC-IN-4 impairs MYC/MAX protein-protein interaction (IC50 = 3.06 μM). MYC-IN-4 inhibits MYC-aberrant PC-3 prostate cancer cells with an IC50 of 0.440 μM. MYC-IN-4 demonstrates potent antitumor efficacy in FVB mice bearing Myc-CaP prostate tumor allografts. MYC-IN-4 can be used for the study of prostate cancer .
loading...
    loading...
Cat. No.: HY-175964
CAS No.: 911714-36-8
Research Areas:  

Cancer

MYC-MAX-IN-1 is a ligands for target protein for PROTAC. MYC-MAX-IN-1 can be used to synthesize PROTAC MDEG-541 (HY-150259).
loading...
    loading...
Cat. No.: HY-169921
Target:  

c-Myc Apoptosis

Research Areas:  

Cancer

c-Myc inhibitor 15 (Compound A5) is a selective c-Myc inhibitor that exerts anticancer effects by disrupting the interaction between c-Myc and Max, leading to the degradation of c-Myc protein and the induction of apoptosis. Its IC50 values are 4.08 μM and 7.86 μM in A549 and NCI-H1299 lung cancer cell lines, respectively, demonstrating strong cytotoxic activity. In a syngeneic tumor model, c-Myc inhibitor 15 exhibited outstanding antitumor efficacy, achieving a tumor growth inhibition rate of 76.4% and significantly reducing c-Myc protein expression levels. c-Myc inhibitor 15 holds promise for research related to c-Myc-driven lung cancers .
loading...
    loading...
Cat. No.: HY-100669R
CAS No.: 944547-46-0
Research Areas:  

Cancer

Mycro 3 (Standard) is the analytical standard of Mycro 3 (HY-100669). This product is intended for research and analytical applications. Mycro 3 is an orally active, potent and selective inhibitor of Myc-associated factor X (MAX) dimerization. Mycro 3 also inhibit DNA binding of c-Myc . Mycro 3 could be used for the research of pancreatic cancer .
loading...
    loading...
Cat. No.: HY-187521
CAS No.: 102537-38-2
Target:  

c-Myc Topoisomerase

Research Areas:  

Cancer

MYCMI-7 hydrobromide is a potent and selective MYC/MYCN inhibitor, with a Kd of 4 μM for MYC and an IC50 of 10 μM for topoisomerase IIα (Topoisomerase IIα). MYCMI-7 hydrobromide binds directly to MYC, selectively inhibits the interactions of MYC:MAX and MYCN:MAX, reduces MYC-driven transcription levels, induces MYC/MYCN protein degradation, and blocks the binding of MYC to chromatin, thereby inducing tumor cell growth arrest, apoptosis and reducing cell viability, while only inducing G1 phase growth arrest in normal cells. MYCMI-7 hydrobromide can be used in research related to MYC-driven acute myeloid leukemia and breast cancer, MYCN-amplified neuroblastoma, glioblastoma, Burkitt's lymphoma, melanoma, colon cancer, osteosarcoma, cervical cancer and histiocytic lymphoma .
loading...
    loading...
Cat. No.: HY-P70388
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MAX; BHLHd5; MYC Associated Transcriptional Regulator X; BHLHd6; MYC Associated Factor X; BHLHd7; BHLHd4; BHLHd8; Protein MAX; MAX Protein; Class D Basic Helix-Loop-Helix Protein 4; BHLHD4; MYC-Associated Factor X; PDMCS
Species:  
Source:  
loading...
    loading...